Multimodality treatment of intrahepatic cholangiocarcinoma: A review

被引：40

作者：

Simo, Kerri A. ^{[1
,2
,3
]}

Halpin, Laura E. ^{[3
]}

McBrier, Nicole M. ^{[1
,2
]}

Hessey, Jacob A. ^{[5
]}

Baker, Erin ^{[4
]}

Ross, Samuel ^{[4
]}

Swan, Ryan Z. ^{[4
]}

Iannitti, David A. ^{[4
]}

Martinie, John B. ^{[4
]}

机构：

[1] ProMed Hlth Syst, Hepatobiliary & Pancreas Surg, Toledo, OH USA

[2] ProMed Hlth Syst, ProMed Canc Inst, Toledo, OH USA

[3] Univ Toledo, Coll Med, Dept Surg, 2801 W Bancroft St, Toledo, OH 43606 USA

[4] Carolinas Med Ctr, Hepatobiliary & Pancreas Surg, Charlotte, NC 28204 USA

[5] Ohio Hlth Riverside Methodist Hosptial, Columbus, OH USA

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2016年 / 113卷 / 01期

关键词：

multimodality; intrahepatic cholangiocarcinoma; SINGLE-CENTER EXPERIENCE; ADVANCED BILIARY-TRACT; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; LYMPH-NODE METASTASIS; ORTHOTOPIC LIVER-TRANSPLANTATION; BODY RADIOTHERAPY SBRT; SEER DATABASE ANALYSIS; LONG-TERM SURVIVAL; PHASE-II TRIAL; PROGNOSTIC-FACTORS;

D O I：

10.1002/jso.24093

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary hepatic cancer in the United States. Currently, curative treatment involves aggressive surgery. Chemotherapy and radiation treatments have been used for unresectable tumors with some success. Optimizing the use of current and developing novel multimodality treatment for iCCA is essential to improving outcomes. J. Surg. Oncol. 2016;113:62-83. (c) 2016 Wiley Periodicals, Inc.

引用

页码：62 / 83

页数：22

共 50 条

[1] The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review
Sposito, Carlo
Busset, Michele Droz Dit
Virdis, Matteo
Citterio, Davide
Flores, Maria
Bongini, Marco
Niger, Monica
Mazzaferro, Vincenzo
EJSO, 2022, 48 (01): : 150 - 159
[2] Multimodality imaging of intrahepatic cholangiocarcinoma
Fabrega-Foster, Kelly
Ghasabeh, Mounes Aliyari
Pawlik, Timothy M.
Kamel, Ihab R.
HEPATOBILIARY SURGERY AND NUTRITION, 2017, 6 (02) : 67 - 78
[3] Management and Extent of Resection for Intrahepatic Cholangiocarcinoma
Carpizo, Darren R.
D'Angelica, Michael
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 18 (02) : 289 - +
[4] Intrahepatic Cholangiocarcinoma: Management Options and Emerging Therapies
Dodson, Rebecca M.
Weiss, Matthew J.
Cosgrove, David
Herman, Joseph M.
Kamel, Ihab
Anders, Robert
Geschwind, Jean-Francois H.
Pawlik, Timothy M.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (04) : 736 - U344
[5] Recurrent Intrahepatic Cholangiocarcinoma - Review
Bekki, Yuki
Von Ahrens, Dagny
Takahashi, Hideo
Schwartz, Myron
Gunasekaran, Ganesh
FRONTIERS IN ONCOLOGY, 2021, 11
[6] Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma: A review of the general principles
Sapisochin, Gonzalo
Ivanics, Tommy
Subramanian, Vijay
Doyle, Majella
Heimbach, Julie K.
Hong, Johnny C.
INTERNATIONAL JOURNAL OF SURGERY, 2020, 82 : 77 - 81
[7] Radiofrequency Ablation for the Treatment of Primary Intrahepatic Cholangiocarcinoma
Kim, Jin Hyoung
Won, Hyung Jin
Shin, Yong Moon
Kim, Kyung-Ah
Kim, Pyo Nyun
AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 196 (02) : W205 - W209
[8] Intrahepatic Cholangiocarcinoma
Poultsides, George A.
Zhu, Andrew X.
Choti, Michael A.
Pawlik, Timothy M.
SURGICAL CLINICS OF NORTH AMERICA, 2010, 90 (04) : 817 - +
[9] Intrahepatic Cholangiocarcinoma
Brown, Kimberly M.
Parmar, Abhishek D.
Geller, David A.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 23 (02) : 231 - +
[10] Management of intrahepatic cholangiocarcinoma: a review for clinicians
Colangelo, Matteo
Di Martino, Marcello
Polidoro, Michela Anna
Forti, Laura
Tober, Nastassja
Gennari, Alessandra
Pagano, Nico
Donadon, Matteo
GASTROENTEROLOGY REPORT, 2025, 13

← 1 2 3 4 5 →